Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for Treatment-Resistant Depression (Chaohu Hospital)
ChiCTR2000041068Phase 4Recruiting
- Sponsor
- Chaohu Hospital of Anhui Medical University
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of esketamine in major depressive disorder (MDD), sponsored by Chaohu Hospital of Anhui Medical University. Primary endpoint: Montgomery Asberg Depression Rating Scale (MADRS). Started Jan 2021; status: recruiting.
02
Drugs
esketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR2000041068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041068.